Cargando…
Methylprednisolone/tocilizumab: Various toxicities, off label use and lack of efficacy: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163913/ http://dx.doi.org/10.1007/s40278-022-16639-6 |
Ejemplares similares
-
Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports
Publicado: (2021) -
Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021) -
Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
Publicado: (2021) -
Methylprednisolone/tocilizumab: Lack of efficacy: case report
Publicado: (2021) -
Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)